Fibrocell Science has submitted an Investigational New Drug Application (IND) with the FDA for a gene therapy candidate to treat moderate to severe localized scleroderma. Fibrocell Science has ...

MADISON, Wis. (Ivanhoe Newswire) — There is new hope for patients with a rare autoimmune disorder. In mild cases, scleroderma causes areas of hardened skin. But in severe cases, it can also cause ...

There is new hope for patients with a rare autoimmune disorder. In mild cases, scleroderma causes areas of hardened skin. But in severe cases, it can also cause deadly hardening of internal organs ...

Please provide your email address to receive an email when new articles are posted on . “Health care providers can use our findings to help people with scleroderma to be physically active despite ...

(NASDAQ: CYTX) today announcedthat an investigator-sponsored and funded clinical study evaluating Cytori’s cell therapy as a potential treatment for and cutaneous systemic sclerosis (scleroderma) has ...

Cyclophosphamide is widely used to treat severe manifestations of numerous autoimmune rheumatic diseases including systemic sclerosis. Based on recent data, immunological and inflammatory activation ...

Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study has now found new cause for optimism using an aggressive stem ...